McMillion Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UNIT
Uniti Group
UNIT
|
+$191K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$616K |
| 2 |
Goldman Sachs
GS
|
+$587K |
| 3 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$432K |
| 4 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$373K |
| 5 |
Southern Company
SO
|
+$370K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.39% |
| 2 | Healthcare | 13.54% |
| 3 | Industrials | 10.48% |
| 4 | Financials | 9.68% |
| 5 | Consumer Discretionary | 9.09% |
Similar funds
McMillion Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, McMillion Capital Management held 57 positions worth $129M, down 4% from $135M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
McMillion Capital Management withdrew a net $7.15M in Q2 2016, closing 1 position and reducing 49 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $310K position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, McMillion Capital Management opened a new position in Uniti Group worth $222K.
- McMillion Capital Management's largest Q2 2016 buy was Uniti Group: 7,693 shares worth $222K.
- McMillion Capital Management's biggest Q2 2016 reduction was Eli Lilly, cutting an estimated $616K.
- McMillion Capital Management fully exited Teva Pharmaceuticals in Q2 2016, selling an estimated $310K.
- McMillion Capital Management's ten largest holdings make up 36% of its $129M portfolio in Q2 2016.
- McMillion Capital Management opened 1 new position and closed 1 in Q2 2016.
- McMillion Capital Management's portfolio value fell 4% quarter-over-quarter to $129M.
Based on McMillion Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.